Title |
Metabolic biomarkers for predicting cardiovascular disease
|
---|---|
Published in |
Vascular Health and Risk Management, January 2013
|
DOI | 10.2147/vhrm.s30378 |
Pubmed ID | |
Authors |
Jana E Montgomery, Jeremiah R Brown |
Abstract |
Cardiac and peripheral vascular biomarkers are increasingly becoming targets of both research and clinical practice. As of 2008, cardiovascular-related medical care accounts for greater than 20% of all the economic costs of illness in the United States. In the age of burgeoning financial pressures on the entire health care system, never has it been more important to try to understand who is at risk for cardiovascular disease in order to prevent new events. In this paper, we will discuss the cost of cardiovascular disease to society, clarify the definition of and need for biomarkers, offer an example of a current biomarker, namely high-sensitivity C-reactive protein, and finally examine the approval process for utilizing these in clinical practice. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 1% |
India | 1 | 1% |
United Kingdom | 1 | 1% |
Mexico | 1 | 1% |
Russia | 1 | 1% |
Unknown | 79 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 18% |
Student > Ph. D. Student | 13 | 15% |
Student > Master | 13 | 15% |
Student > Bachelor | 9 | 11% |
Other | 7 | 8% |
Other | 16 | 19% |
Unknown | 11 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 33% |
Agricultural and Biological Sciences | 10 | 12% |
Biochemistry, Genetics and Molecular Biology | 9 | 11% |
Chemistry | 4 | 5% |
Engineering | 4 | 5% |
Other | 11 | 13% |
Unknown | 18 | 21% |